Skip to main content

Table 2 Means (± s.d) of the TGF-β 1 and PDGF-BB concentrations (pg/mg of total protein (TP)) in every blood component obtained with every anticoagulant

From: Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel

Variable

Blood component

 

Plasma

P-PRP lysate

P-PRG

PPP lysate

PPG

SC

     

PDGF-BB (pg/mg of TP)

0.9 (0.6)a,b

25.2 (14.4)c

19.0 (29.4)d

8.3 (5.4)d

4.5 (5.5)

TGF-β1(pg/mg of TP)*

26.8 (10.4)a,e

90.7 (30.7)c,e

54.5 (33.1)

45.2 (10.3)d

29.2 (17.1)

ACD-A

     

PDGF-BB (pg/mg of PT)

1.0 (0.6)a,b

28.2 (20.1)c

11.3 (30.6)

8.2 (5.0)

5.8 (8.0)

TGF-β1(pg/mg of TP)*

30.0 (8.7)a

101.5 (31.2)c,e

56.4 (39.1)

47.8 (12.2)

33.3 (17.9)

ACD-B

     

PDGF-BB (pg/mg of TP)

1.1 (0.9)a

18.4 (13.4)b

6.6 (17.3)

7.2 (4.1)

4.8 (6.5)

TGF-β1(pg/mg of TP)*

27.5 (10.0)c

87.8 (23.0)d

50.8 (31.2)

44.6 (12.9)

31.3 (12.7)

  1. *Data are presented as medians (IR). P-PRG: pure platelet-rich gel; PPG: platelet-poor gel. Lowercase letters represent independent significant differences for every blood component obtained with a specific anticoagulant. SC: blood component different with a: P-PRP and PPP lysates (P <0.001); b: P-PRG and PPG (P <0.05); c: PPP lysate and PPG (P <0.001); d: PPG (P <0.05); and e: P-PRG (P <0.05). ACD-A: blood component different with a: P-PRP and PPP lysates (P <0.001); b: P-PRG and PPG (P <0.05); c: PPP lysate and PPG (P <0.001); d: PPG; and e: P-PRG (P <0.05). ACD-B: blood component different a: all blood components (P <0.05); b: PPP lysate and PPP (P <0.05); c: P-PRP lysate (P <0.05); d: PPP lysate and PPG (P <0.05).